An increasing number of Chinese pharmaceutical companies, in particular privately-owned firms in coastal areas, are eyeing the international market.
Domestic companies are working to counteract the on-going dumping claims. They understand that they might totally lose the target market if they do not respond.
Chinese pharmaceutical companies are seeing more anti-dumping or anti-subsidy cases. The conflicts are spreading to some major exports.
Global demand for China's pharmaceuticals is strong.
Copyright © 2024 Electric Goat Media. All Rights Reserved.